Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Naik Vietti VioliSara LewisJoseph LiaoMiriam HulkowerGabriela Hernandez-MezaKatherine SmithJames S BabbXing ChinJoseph SongDaniela SaidShingo KihiraClaude B SirlinScott B ReederMustafa R BashirKathryn J FowlerBart S FerketKeith SigelBachir A TaouliPublished in: European radiology (2020)
• Comparison of different abbreviated MRI (AMRI) sets reconstructed from a complete gadoxetate MRI demonstrated that non-contrast AMRI has low sensitivity (61.5%) compared with contrast-enhanced AMRI (80.8% for hepatobiliary phase AMRI and 84.6% for dynamic AMRI), with all sets having high specificity. • Non-contrast and hepatobiliary phase AMRI can be performed in less than 14 min (including set-up time), while dynamic AMRI can be performed in less than 17 min. • All AMRI sets were cost-effective for HCC screening in at-risk population in comparison with ultrasound.